Cancer Answers: Cancer Prevention 2019
July 25, 2019- 00:00Support for Yale Cancer Center Answers comes from AstraZeneca, a global biopharmaceutical company that is committed to bringing to immuno-oncology to people living with earlier stages of cancer. Learn more at astrazeneca-us.com. 00:15.200 --> 00:50.500 Welcome to Yale Cancer Answers with doctors Anees Chagpar and Steven Gore. I am Bruce Barber. Yale Cancer Answers features the latest information on cancer care by welcoming oncologists and specialists who are on the forefront of the battle to fight cancer. This week, it is a conversation about cancer prevention and control with Dr. Melinda Irwin. Dr. Irwin is Professor of Epidemiology at the Yale School of Public Health and Co-Program Leader of the cancer prevention and control research program at Yale Cancer Center. Dr. Chagpar is a Professor of Surgery at Yale School of Medicine.
- 13:39Medical Minute Support for Yale Cancer Answers comes from AstraZeneca, creator of 5 new FDA-approved cancer therapies in the last 4 years and on track to provide patients with 6 new medicines by 2020. Learn more at astrazeneca-us.com. 13:55.700 --> 14:54.700 This is a medical minute about smoking cessation. There are many obstacles to face when quitting smoking as smoking involves the potent drug nicotine, but it is a very important lifestyle change, especially if a patient is undergoing cancer treatment. Quitting smoking has been shown to positively impact response to treatments, decrease the likelihood that patients will develop second malignancies and increase rates of survival. Tobacco treatment programs are currently being offered at federally designated comprehensive cancer centers and operate on the principles of the US Public Health Service Clinical Practice Guidelines. All treatment components are evidence based and therefore all patients are treated with FDA-approved first-line medications for smoking cessation as well as smoking cessation counseling that stresses appropriate coping skills. More information is available at YaleCancerCenter.org. You are listening to Connecticut Public Radio. 14:54.700 --> 15:46.700
- 28:42Dr. Melinda Irwin is Professor of Epidemiology at the Yale School of Public Health and Co-Program Leader of the cancer prevention and control research program at Yale Cancer Center. If you have questions, the address is canceranswers@yale.edu and past editions of the program are available in audio and written form at YaleCancerCenter.org. I am Bruce Barber reminding you to tune in each week to learn more about the fight against cancer here on Connecticut Public Radio.